MVF Monash IVF shares cater 25% – Disaster or deep-value play? Monash IVF Group (ASX:MVF) is back in the headlines, and for all the wrong reasons. Shares have plunged 25% following news of a second embryo mix-up this year, and for many investors, it’s déjà vu.Listen to the HotCopper podcast for in-depth discussions and insights on all the big... Dale Gillham 27 Jun 2025 15:40 (AEST) ASX News Contributors & Collaborations Healthcare Medical Care
AYA Artrya pops +11% on yet another FDA approval for an Aussie biotech Artrya (ASX:AYA) is the latest Aussie biotech stock to see an FDA approval and consequent rewarding share price jump from traders and investors. Jonathon Davidson 28 Mar 2025 11:50 (AEDT) ASX News Healthcare Medical Care
COV CLEO Diagnostics kicks off IP transfer for ovarian cancer blood tests to US manufacturers CLEO Diagnostics has commenced the 'technology transfer' process to a US-based manufacturing partner ahead of commercialisation. Jonathon Davidson 18 Mar 2025 12:24 (AEDT) ASX News Healthcare Medical Care
